Mary Barra (GM) Exercises Options and Sells 29,486 Shares; 2019 Grants Fully Vested
Rhea-AI Filing Summary
Mary T. Barra, Chair & CEO of General Motors Co (GM), reported option exercise and share sale on 09/12/2025. She acquired 29,486 shares through the exercise of employee stock options at a $39 exercise price and simultaneously sold 29,486 shares at a weighted average price of $59.92. The filing notes the exercise relates to options granted on February 13, 2019, which are fully vested. The report also states 81,289 shares were returned to Ms. Barra upon completion of a final GRAT annuity as previously disclosed. After the transactions, the filing shows beneficial ownership figures of 663,013 shares (after the acquisition) and 633,527 shares (after the sale), and 205,514 derivative securities remaining outstanding.
Positive
- Exercise and sale were executed on the same date, indicating a coordinated liquidity event
- Sale price materially exceeded the $39 exercise price (weighted average sale $59.92), implying realized value
Negative
- None.
Insights
TL;DR: CEO exercised vested options and sold the same number of shares, realizing value above exercise price; holdings remain substantial.
The filing documents a routine executive liquidity event: 29,486 options exercised at a $39 strike and an equal number of shares sold at a weighted average of $59.92 on 09/12/2025, implying proceeds materially above the exercise cost per share. The options were granted in 2019 and are fully vested, and the report confirms the reporting person retains significant direct and derivative ownership: 633,527 shares after sale and 205,514 options outstanding. The filing additionally records distribution of 81,289 shares from a GRAT settlement previously disclosed. This is a transactional disclosure rather than a change in corporate strategy or governance.
TL;DR: Transaction appears compliant and routine; signature filed by attorney-in-fact and includes required explanatory footnotes.
The Form 4 contains standard disclosures including transaction codes, weighted average sale price range, and an explanatory footnote regarding a GRAT distribution. The signature is by an attorney-in-fact, and the filer indicates the sale was executed pursuant to a written plan condition (checked box referencing Rule 10b5-1(c)), which supports affirmative-defense disclosure. There are no disclosures of new grants, departures, or governance changes in this filing.